Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Cytos Biotech Signed License Agreement with Novartis for Nicotine Addiction Vaccine [PharmaGazette]

knowmoremedia.com » 2007 » April » 27th » Cytos Biotech Signed License Agreement with Novartis for Nicotine Addiction Vaccine [PharmaGazette]

Tagged: nvs, novartis, research and development, manufacturers and mergers

Cytos Biotechnology AG (SWX: CYTN) has entered into an exclusive global commercial license agreement with Novartis (NYSE:NVS) for the development, manufacturing and commercialization of CYT002-NicQb – a novel therapeutic vaccine under phase II clinical development for the treatment of nicotine addiction. The terms of agreement include: Novartis is granted world-wide exclusive rights for Continue Reading »


Latest news from Know More Media - Health Care / Pharmaceutical / Fitness:

  1. Shire Warning Letter Is About Content, Not Context [HealthCareVox]
  2. Help Pew Tweak Its Next Internet Survey [HealthCareVox]
  3. If You’re Conducting Telephone Surveys You Must Include Cell-Only Population [HealthCareVox]
  4. More On Health 2.0: Are Consumers Central Or Secondary? [HealthCareVox]
  5. Health 2.0: Fad Or Fundamental? [HealthCareVox]

Latest news from knowmoremedia.com:

  1. A Memorandum in Colors
  2. A Memorandum in Colors [Webmetricsguru]
  3. Head for the Silicon Valley storm cellar. But get a value proposition first.
  4. Head for the Silicon Valley storm cellar. But get a value proposition first. [BrandingPost]
  5. Shire Warning Letter Is About Content, Not Context